Congratulations to all members of the Department who have recently been awarded research grants. Here is our round-up of the latest funding successes.
Please note, this list comprises awards that have recently been set up on College’s grants management system, with some manual additions. It may not, therefore, include all new grants awarded to Principal Investigators in the Department.
|Principal Investigator||Group||Funder||Funding Scheme||Proposal Title||Awarded Amount (£)|
|Professor Simone Di Giovanni||Neuroscience||Department of the Army||SCIRP Investigator initiated research award programme||Monoclonal antibody against CXCL13 to promote axonal plasticity, regeneration and functional recovery after spinal cord injury: a translational opportunity||372,398|
|Professor Simone Di Giovanni||Neuroscience||Associazione Maria Romoli Onlus||N/A||IDENTIFICATION OF FIBER TRACT-SPECIFIC CELLULAR MICRODOMAINS AFTER ACUTE AND CHRONIC SCI||144,000|
|Professor Simone Di Giovanni||Neuroscience||Rosetrees Trust||Major Project Grant||Monoclonal antibody against CXCL13 to promote axonal plasticity, regeneration and functional recovery after spinal cord injury||200,000|
|Dr Joseph Kwan||Clinical Neurology||Imperial College Healthcare NHS Trust- BRC Funding||N/A||Pilot for database development and West London data collection “Stroke Thrombectomy Research Registry”||20,000|
|Dr Nathan Skene||Neuroscience||UK DRI Ltd||UK DRI COLLABORATIVE SINGLE CELL AND SPATIAL TRANSCRIPTOMICS STUDIES AWARD PROGRAMME||Amplifying genome coverage of single cell epigenetic profiling of the human brain||10,001|
|Professor Dipankar Nandi||Clinical Neurology||Imperial College Healthcare NHS Trust- BRC Funding||N/A||Pilot Project – The Effect on Glioblastoma Recurrence in Surgically Debulked Patients Unable to Proceed to Standard Adjuvant Therapy due to Covid-19||10,000|
|Professor Dipankar Nandi||Clinical Neurology||Imperial College Healthcare NHS Trust- BRC Funding||N/A||Pilot Project – The effect of COVID-19 on post-operative neurosurgical infection across two acute sites in the Imperial College Healthcare NHS Trust||5,000|